Prevalence and incidence of anemia in the German Heinz Nixdorf Recall Study

[1]  Preet Paul Singh,et al.  Polyclonal immunoglobulin free light chain levels predict survival in myeloid neoplasms. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  C. Roy,et al.  Not so benign haematology: anaemia of the elderly , 2012, British journal of haematology.

[3]  R. Lieb,et al.  Population-Based Study , 2012 .

[4]  S. Moebus,et al.  Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany , 2012, Annals of Hematology.

[5]  J. Coad,et al.  Iron deficiency in women: assessment, causes and consequences , 2011, Current opinion in clinical nutrition and metabolic care.

[6]  C. Hutchison,et al.  Polyclonal immunoglobulin free light chains as a potential biomarker of immune stimulation and inflammation. , 2011, Clinical chemistry.

[7]  J. Waalen,et al.  Erythropoietin, GDF15, IL6, hepcidin and testosterone levels in a large cohort of elderly individuals with anaemia of known and unknown cause , 2011, European journal of haematology.

[8]  A. Artz,et al.  Unexplained anemia predominates despite an intensive evaluation in a racially diverse cohort of older adults from a referral anemia clinic. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.

[9]  S. Moebus,et al.  Polyclonal Free Light Chain Elevation and Mortality In the German Heinz Nixdorf Recall Study , 2010 .

[10]  G. Apolone,et al.  Prevalence, incidence and types of mild anemia in the elderly: the “Health and Anemia” population-based study , 2010, Haematologica.

[11]  S. Bandinelli,et al.  Proinflammatory state, hepcidin, and anemia in older persons. , 2010, Blood.

[12]  C. Hutchison,et al.  Serum free light chain assessment in monoclonal gammopathy and kidney disease , 2009, Nature Reviews Nephrology.

[13]  M Boccadoro,et al.  International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders , 2009, Leukemia.

[14]  D. Pittrow,et al.  Prevalence of anemia in elderly patients in primary care: impact on 5-year mortality risk and differences between men and women. , 2009, Current medical research and opinion.

[15]  J. J. Rivera,et al.  Markers of inflammation and coronary artery calcification: a systematic review. , 2008, Atherosclerosis.

[16]  G. Mead,et al.  Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[17]  Sheena Derry,et al.  Prevalence of anaemia in older persons: systematic review , 2008, BMC geriatrics.

[18]  S. Bandinelli,et al.  Low testosterone levels and the risk of anemia in older men and women. , 2006, Archives of internal medicine.

[19]  S. Bandinelli,et al.  Proinflammatory state and circulating erythropoietin in persons with and without anemia. , 2005, The American journal of medicine.

[20]  S. Moebus,et al.  Baseline recruitment and analyses of nonresponse of the Heinz Nixdorf recall study: Identifiability of phone numbers as the major determinant of response , 2005, European Journal of Epidemiology.

[21]  L. Goodnough,et al.  Anemia of chronic disease. , 2005, The New England journal of medicine.

[22]  Luigi Ferrucci,et al.  Serum Erythropoietin and Aging: A Longitudinal Analysis. , 2004 .

[23]  Luigi Ferrucci,et al.  Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. , 2004, Blood.

[24]  J. Katzmann,et al.  Serum Reference Intervals and Diagnostic Ranges for Free κ and Free λ Immunoglobulin Light Chains: Relative Sensitivity for Detection of Monoclonal Light Chains , 2002 .

[25]  D. Grönemeyer,et al.  Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. , 2002, American heart journal.

[26]  J. Katzmann,et al.  Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. , 2002, Clinical chemistry.

[27]  S. Grundy.  Coronary calcium as a risk factor: role in global risk assessment. , 2001, Journal of the American College of Cardiology.

[28]  M. Drayson,et al.  Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. , 2001, Clinical chemistry.

[29]  F. Caird,et al.  Anaemia in the elderly. , 1973, The Quarterly journal of medicine.